These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 7813586

  • 21. SIN-1 stimulates the production of cyclic GMP but not cyclic AMP in porcine aortic endothelial cells.
    Schini VB, Vanhoutte PM.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S91-4. PubMed ID: 2484708
    [Abstract] [Full Text] [Related]

  • 22. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH, Haslam RJ.
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [Abstract] [Full Text] [Related]

  • 23. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
    Fisch A, Michael-Hepp J, Meyer J, Darius H.
    Eur J Pharmacol; 1995 May 26; 289(3):455-61. PubMed ID: 7556414
    [Abstract] [Full Text] [Related]

  • 24. Negative metabolic effects of cyclic GMP are altered in renal hypertension induced cardiac hypertrophy.
    Rabindranauth P, Naim KL, Scholz PM, Tse J, Sadoff JD, Weiss HR.
    Basic Res Cardiol; 1997 Feb 26; 92(1):8-16. PubMed ID: 9062647
    [Abstract] [Full Text] [Related]

  • 25. Molsidomine inhibits the chemoattractant-induced respiratory burst in human neutrophils via a no-independent mechanism.
    Ervens J, Seifert R.
    Biochem Pharmacol; 1992 Aug 18; 44(4):637-44. PubMed ID: 1324680
    [Abstract] [Full Text] [Related]

  • 26. Influence of nitric oxide synthase inhibition, nitric oxide and hydroperoxide on insulin release induced by various secretagogues.
    Panagiotidis G, Akesson B, Rydell EL, Lundquist I.
    Br J Pharmacol; 1995 Jan 18; 114(2):289-96. PubMed ID: 7533613
    [Abstract] [Full Text] [Related]

  • 27. Neuronal death induced by SIN-1 in the presence of superoxide dismutase: protection by cyclic GMP.
    Moro MA, Fernández-Tomé P, Leza JC, Lorenzo P, Lizasoain I.
    Neuropharmacology; 1998 Aug 18; 37(8):1071-9. PubMed ID: 9833636
    [Abstract] [Full Text] [Related]

  • 28. Clinical tolerance to nitroglycerin is due to impaired biotransformation of nitroglycerin and biological counterregulation, not to desensitization of guanylate cyclase.
    Mülsch A, Busse R, Bassenge E.
    Z Kardiol; 1989 Aug 18; 78 Suppl 2():22-5; discussion 64-7. PubMed ID: 2573982
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Ionophore A23187-induced leukotriene biosynthesis in equine granulocytes-neutrophils, but not eosinophils require exogenous arachidonic acid.
    Lindberg A, Tornhamre S, Mugnai S, Lindgren J.
    Biochim Biophys Acta; 1998 Mar 30; 1391(2):247-55. PubMed ID: 9555040
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
    Ebihara Y, Karmazyn M.
    Cardiovasc Res; 1996 Sep 30; 32(3):622-9. PubMed ID: 8881523
    [Abstract] [Full Text] [Related]

  • 33. Positive and negative inotropic effects of NO donors in atrial and ventricular fibres of the frog heart.
    Chesnais JM, Fischmeister R, Méry PF.
    J Physiol; 1999 Jul 15; 518 ( Pt 2)(Pt 2):449-61. PubMed ID: 10381591
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of platelet arachidonic acid liberation by endothelium-derived relaxing factor (EDRF) as studied with sin-1, a nitric oxide generating drug. Evidence for calcium-dependent and calcium-independent mechanisms.
    Gassama-Diagne A, Simon MF, Chap H.
    J Lipid Mediat; 1992 Feb 15; 5(1):61-75. PubMed ID: 1327266
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Tolerance and cross-tolerance between SIN-1 and nitric oxide in bovine coronary arteries.
    Kukovetz WR, Holzmann S.
    J Cardiovasc Pharmacol; 1989 Feb 15; 14 Suppl 11():S40-6. PubMed ID: 2484698
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of calcium influx in thrombin-stimulated platelets by SIN-1, an activator of soluble guanylate cyclase.
    Simon MF, Chap H.
    J Cardiovasc Pharmacol; 1989 Feb 15; 14 Suppl 11():S106-10. PubMed ID: 2484686
    [Abstract] [Full Text] [Related]

  • 38. Exogenous nitric oxide reduces oxygen consumption of isolated ventricular myocytes less than other forms of guanylate cyclase stimulation.
    Gong GX, Weiss HR, Tse J, Scholz PM.
    Eur J Pharmacol; 1998 Mar 05; 344(2-3):299-305. PubMed ID: 9600666
    [Abstract] [Full Text] [Related]

  • 39. Cyclic AMP and cyclic GMP independent stimulation of ventricular calcium current by peroxynitrite donors in guinea pig myocytes.
    Malan D, Levi RC, Alloatti G, Marcantoni A, Bedendi I, Gallo MP.
    J Cell Physiol; 2003 Nov 05; 197(2):284-96. PubMed ID: 14502568
    [Abstract] [Full Text] [Related]

  • 40. Nitric oxide regulates the calcium current in isolated human atrial myocytes.
    Kirstein M, Rivet-Bastide M, Hatem S, Bénardeau A, Mercadier JJ, Fischmeister R.
    J Clin Invest; 1995 Feb 05; 95(2):794-802. PubMed ID: 7860763
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.